India may seek the setting up of a special panel within the World Trade Organization to resolve the dispute with the European Union (EU) over the seizure of generic drug exports. The commerce ministry is ready to push for this at the WTO in the next week after months-long consultations with the concerned authorities, said a ministry official familiar with the development. Commerce secretary Rahul Khullar said both sides are still talking...

Even as India and the European Union (EU) inch closer to threshing out a free-trade agreement, the unresolved issue of seizures by EU member countries of Indian generic drugs on their way to other destinations continues to sour relations between the two. Over a score of such incidents of unlawful confiscation of Indian drug shipments by European customs authorities have occurred in the past three years. Ironically, most of such...

Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical...

The discussion paper on compulsory licensing of patents will have achieved its purpose if it can lead to a proactive policy in the area of drugs and health. IN a proactive move to ensure a fair balance between protection of intellectual property rights and protection of the public interest, the Department of Industrial Policy and Promotion (DIPP) of the Ministry of Commerce and Industry has chosen to put out a discussion...

Their ongoing negotiations remain shrouded in secrecy, but there are already reports that India and the European Union (EU) will have a free-trade agreement ready by the end of August, and that they will be putting signatures to it before the end of 2010. Yet it is a potential development that is causing more nervous chatter than joyous jitters here in India, where drug manufacturers in particular have raised concerns over...